$MCET IDEAL BIOSTENT XENOGENICS ---> POST CLINAL TRIALS 1st Bioresorbable Scaffolds Stent Ideal Biostent Strut Composition PLA anhydride Drug elution Sirolimus Company Xenogenics Development ---> Pre-clinical ---> Clinical trials 1st ---> Post Clinal Trials 1st ####READ THIS COMPLETE#### http://sbhci.org.br/2013/wp-content/uploads/2013/08/26/cacau/YaronAlmagor.pdf